Melanotan IIUnderstand the science
What Melanotan II Revealed About Appetite Signaling in Mice
2 numbered sourcesSource years 2026
Peptides are short chains of amino acids joined by peptide bonds. Some act as signals by binding to receptors, which are proteins that respond to particular molecules. Melanotan II is a synthetic peptide modeled on a natural melanocortin signal. It activates several melanocortin receptors. A September 2026 study used it to test how one of those receptors, MC4R, helps control feeding in mice. [1, 2]
The researchers studied attractin-like protein 1, known as ATRNL1. They wanted to know whether MC4R could produce its usual effect in a part of the hypothalamus when that partner protein was absent. They removed ATRNL1 from neurons in that region in adult mice and compared them with mice whose protein was intact. Making the change in adulthood helped the team test whether the protein mattered after the brain had developed. [1]
The team compared food intake after exposure to Melanotan II or a saline control. Male and female mice with intact ATRNL1 ate less after the peptide exposure than after saline. The reduction was smaller in mice missing ATRNL1 in the targeted region. In a separate cell experiment, ATRNL1 strengthened one response of MC4R to its natural peptide signal without increasing the measured number of receptors at the cell surface. That cell experiment used the natural signal, whereas the mouse feeding experiment used Melanotan II. [1]
A separate 2026 study tested another protein, beta-arrestin-2. In that study, Melanotan II reduced short-term feeding in control mice but did not suppress feeding in mice lacking beta-arrestin-2 in MC4R-expressing neurons. Some measured changes in energy use still occurred. Taken together, the experiments help show why the response to a peptide depends on what the receptor and its partner proteins do inside a particular cell. [1, 2]
These were tests of a biological pathway. The feeding experiments measured how much laboratory animals ate over a short period under controlled conditions. A trial of sustained weight change in people would need to measure different outcomes, including how long changes last and what harms occur. Neither feeding experiment supplies those answers for Melanotan II. [1, 2]
Sources
Original works cited in this article. Links open the external record in a new tab.
